Home › Cancer (all types) › NCT05838638

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Serious Gaming for Chemotherapy-induced Nausea and Vomiting in Older Adults With Cancer: A Randomized Clinical Trial

Who can join

Ages 60 and older · All sexes

Inclusion Criteria:

* age 60 or older
* newly diagnosed with cancer
* treatment with any chemotherapeutic agent of moderate or high emetic potential
* on a 2, 3 or 4 week treatment cycle
* proficient in English
* has a telephone

Exclusion Criteria:

* previous diagnosis and/or treatment for cancer
* end stage disease with less than 6 months to live
* visually or hearing impaired without corrective device

About the study

The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.

What is being tested

• eSSET-CINV (behavioral)

Sponsor: University of Central Florida · Participants: 610 · Started: Jun 9, 2023

Contact the study team

• Victoria Loerzel, PhD · Phone: 407-823-0762
• Michael Owings · Phone: 407-440-1309

Official record on ClinicalTrials.gov — NCT05838638

Locations in the U.S.

Conditions

• Cancer (all types)
• Nausea and Vomiting
• Drug Reactions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.